DalsnaFinance › IPOs › Autolus Therapeutics › IPO
Autolus Therapeutics plc completed its initial public offering on NASDAQ on June 22, 2018, pricing at $17.00 a share.
| Ticker | AUTL |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 22, 2018 |
| Offering price | $17.00 |
| Shares offered | 8,823,530 |
| Total raised | $150M |
Autolus Therapeutics plc sold 8,823,530 shares at $17.00 each on NASDAQ. Multiplied out, that is $150 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $150 million total recorded for the deal.
Autolus Therapeutics plc — quote, profile and latest news →
Source: SEC EDGAR filings for Autolus Therapeutics plc. This page is general information, not investment advice.